Bausch Health Cos Price to Sales Ratio 2010-2023 | BHC
Historical PS ratio values for Bausch Health Cos (BHC) over the last 10 years. The current P/S ratio for Bausch Health Cos as of April 26, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bausch Health Cos P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-04-26 |
8.71 |
|
0.35 |
| 2023-12-31 |
8.02 |
$24.68 |
0.32 |
| 2023-09-30 |
8.22 |
$23.72 |
0.35 |
| 2023-06-30 |
8.00 |
$23.02 |
0.35 |
| 2022-12-31 |
6.28 |
$22.43 |
0.28 |
| 2022-09-30 |
6.89 |
$22.50 |
0.31 |
| 2022-06-30 |
8.36 |
$22.22 |
0.38 |
| 2022-03-31 |
22.85 |
$22.59 |
1.01 |
| 2021-12-31 |
27.61 |
$23.12 |
1.19 |
| 2023-03-31 |
8.10 |
$22.68 |
0.36 |
| 2021-09-30 |
27.85 |
$23.56 |
1.18 |
| 2021-06-30 |
29.32 |
$23.74 |
1.24 |
| 2021-03-31 |
31.74 |
$22.57 |
1.41 |
| 2020-12-31 |
20.80 |
$22.59 |
0.92 |
| 2020-09-30 |
15.54 |
$22.67 |
0.69 |
| 2020-06-30 |
18.29 |
$22.96 |
0.80 |
| 2020-03-31 |
15.50 |
$24.39 |
0.64 |
| 2019-12-31 |
29.92 |
$24.44 |
1.22 |
| 2019-09-30 |
21.85 |
$24.16 |
0.90 |
| 2019-06-30 |
25.22 |
$23.96 |
1.05 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.183B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
